Licensing under the Medicines Act and its effect on pharmacy.
作者信息
Fishburn A G
出版信息
R Soc Health J. 1974 Dec;94(6):271-3, 95. doi: 10.1177/146642407409400604.
PMID:4460083
Abstract
摘要
相似文献
1
Licensing under the Medicines Act and its effect on pharmacy.
R Soc Health J. 1974 Dec;94(6):271-3, 95. doi: 10.1177/146642407409400604.
2
Inspections: the international regulatory view.检查：国际监管视角
PDA J Pharm Sci Technol. 1994 Jul-Aug;48(4):180-1.
3
Inspections: the international regulatory view--Japan.检查：国际监管视角——日本
PDA J Pharm Sci Technol. 1994 Jul-Aug;48(4):182-3.
4
The Committee on Review of Medicines.药品审查委员会
J Clin Hosp Pharm. 1985 Jun;10(2):137-41. doi: 10.1111/j.1365-2710.1985.tb01128.x.
5
The joint interagency task force and the global steering committee for the quality assurance of health products: two new and proactive approaches promoting access to safe and effective medicines.卫生产品质量保证联合跨部门特别工作组和全球指导委员会：促进获取安全有效药物的两种新的积极方法。
Am J Trop Med Hyg. 2015 Jun;92(6 Suppl):133-136. doi: 10.4269/ajtmh.15-0208.
6
Counterfeiting and piracy of pharmaceuticals.药品的假冒和盗版。
IEEE Eng Med Biol Mag. 2008 Nov-Dec;27(6):66-9. doi: 10.1109/MEMB.2008.929891.
7
Legislation on medicines.药品法规
Br Med J. 1970 Sep 26;3(5725):760-2. doi: 10.1136/bmj.3.5725.760.
8
The primacy of public health considerations in defining poor quality medicines.优先考虑公共卫生因素来定义劣质药品。
PLoS Med. 2011 Dec;8(12):e1001139. doi: 10.1371/journal.pmed.1001139. Epub 2011 Dec 6.
9
WHO expert committee on specifications for pharmaceutical preparations.世界卫生组织药物制剂规范专家委员会
World Health Organ Tech Rep Ser. 2013(981):i-xi, 1-188.
10
Global perspective on specifications for biotechnology products--perspective from Japan.生物技术产品规范的全球视角——来自日本的视角
Dev Biol Stand. 1997;91:15-23.
Zotero 插件